Institutions / Frazier Life Sciences Management, L.P. / Holdings
Back to Frazier Life Sciences Management, L.P.

Frazier Life Sciences Management, L.P.

All holdings · as of Dec 31, 2025

40 positions

CompanyClassValue ↓Shares% of portfolio
NEWAMSTERDAM PHARMA COMPANY—$594.39M16,943,77416.0%
Mirum Pharmaceuticals, Inc.—$536.75M6,795,12114.4%
Arcutis Biotherapeutics, Inc.—$286.76M9,874,5117.7%
BridgeBio Pharma, Inc.—$271.20M3,545,5577.3%
MBX Biosciences, Inc.MBXCommon Stock$209.80M6,652,0135.6%
Phathom Pharmaceuticals, Inc.PHATCommon Stock$206.82M12,466,4895.6%
Maze Therapeutics, Inc.—$189.22M4,567,2745.1%
Trevi Therapeutics, Inc.—$128.45M10,259,4093.4%
Krystal Biotech, Inc.—$120.42M488,4603.2%
Disc Medicine, Inc.IRONCommon Stock$100.06M1,260,0002.7%
Erasca, Inc.ERASCommon Stock$84.55M22,729,4362.3%
KalVista Pharmaceuticals Inc—$81.39M5,039,8672.2%
PALVELLA THERAPEUTICS, INC.PVLACommon Stock$75.61M722,4002.0%
Avidity Biosciences, Inc.—$70.91M983,1251.9%
Revolution Medicines, Inc.—$63.52M797,4551.7%
Dyne Therapeutics, Inc.—$61.67M3,153,0821.7%
TARSUS PHARMACEUTICALS, INC.—$59.66M728,6441.6%
Savara IncSVRACommon Stock$59.47M9,862,3011.6%
Cytokinetics Inc—$59.39M934,6421.6%
ABIVAX SA—$51.02M378,3001.4%
Lexeo Therapeutics, Inc.—$43.94M4,424,7251.2%
AGIOS PHARMACEUTICALS, INC.—$34.83M1,279,7540.9%
ACADIA Pharmaceuticals Inc—$34.65M1,297,1980.9%
Zai Lab Limited—$33.56M1,902,3200.9%
RAPT THERAPEUTICS INC—$33.31M983,3330.9%
Vor Biopharma Inc.—$33.27M2,543,9390.9%
ASCENDIS PHARMA A/S—$28.43M133,3330.8%
Aura Biosciences, Inc.AURACommon Stock$27.80M5,100,0000.7%
MANNKIND CORP—$23.96M4,225,0000.6%
VALNEVA SE—$20.21M2,291,6660.5%
Alkermes plc.—$19.60M700,6470.5%
Evolus, Inc.—$17.49M2,630,6650.5%
IMMUNOCORE HOLDINGS PLC-ADRIMCRADR$13.36M384,7820.4%
NEWAMSTERDAM PHARMA COMPANY—$11.51M500,3330.3%
Travere Therapeutics, Inc.—$9.23M241,5920.2%
Autolus Therapeutics plcAUTLADR$9.20M4,623,3240.2%
Allogene Therapeutics, Inc.—$5.30M3,868,7500.1%
Design Therapeutics, Inc.DSGNCommon Stock$4.89M521,0000.1%
XILIO THERAPEUTICS INC—$3.79M5,915,0910.1%
iBio, Inc.IBIOCommon Stock$3.77M1,953,4670.1%
← PrevPage 1 of 1Next →